Celularity, Inc. (CELU)
0.9777
-0.07
(-6.89%)
USD |
NASDAQ |
Oct 23, 16:00
0.9606
-0.02
(-1.75%)
After-Hours: 20:00
Celularity Debt to Equity Ratio : -1.965 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.965 |
| March 31, 2026 | -1.931 |
| December 31, 2025 | -1.963 |
| September 30, 2025 | -3.322 |
| June 30, 2025 | -2.752 |
| March 31, 2025 | -12.67 |
| December 31, 2024 | 7.790 |
| September 30, 2024 | 3.997 |
| June 30, 2024 | 2.422 |
| March 31, 2024 | 2.114 |
| December 31, 2023 | 1.597 |
| September 30, 2023 | 2.019 |
| June 30, 2023 | 0.5227 |
| March 31, 2023 | 0.4096 |
| December 31, 2022 | 0.3298 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.409 |
| June 30, 2022 | 0.1855 |
| March 31, 2022 | 0.3388 |
| December 31, 2021 | 0.3132 |
| September 30, 2021 | 0.3229 |
| June 30, 2021 | 0.0137 |
| March 31, 2021 | -0.5004 |
| December 31, 2020 | 1.638 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Exicure, Inc. | 0.00 |
| Century Therapeutics, Inc. | 0.1664 |
| Absci Corp. | 0.0156 |
| Cardio Diagnostics Holdings, Inc. | 0.0498 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 96.17M |
| Total Liabilities (Quarterly) | 131.70M |
| Shareholders Equity (Quarterly) | -35.53M |
| Current Ratio | 0.1079 |
| Net Debt Paydown Yield | -0.07% |